Skip to main content

Table 4 Change of liver function before and after GSMs-TACE \((\overline{x}\pm s)\)  

From: Clinical application of gelatin sponge microparticles combined with pirarubicin for hepatic transcatheter arterial chemoembolization in breast cancer liver metastasis treatment: results of a single-center long-term study

  Pre-TACE 7 days after TACE P
ALT (U/L) 50.70 ± 16.15 59.33 ± 17.53 0.052
AST (U/L) 49.41 ± 14.27 57.79 ± 16.91 0.054
TBIL (μmol/L) 24.53 ± 10.13 30.63 ± 11.58 0.063
ALB (g/L) 36.04 ± 7.23 32.19 ± 4.06 0.051